Document Classification

Section Type: RESULTS

Text: In this cohort at 12 months, those given prasugrel experienced significantly fewer ischemic events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke, 7. 8 % vs 10. 5 %, hazard ratio (HR) = 0. 73, p < 0. 001, than those given clopidogrel, with a non-significant increase in non-coronary artery bypass graft (CABG) TIMI major bleeding, 1. 7 % vs 1. 5 %, HR = 1. 15, p = 0. 40 ; similarly, in the overall cohort these frequencies were 9. 4 % vs 11. 4 %, HR = 0. 81, p < 0. 001, for cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke, and 2. 2 % vs 1. 8 %, HR = 1. 24, p = 0. 10, for non-CABG TIMI major bleeding.